Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature

MLA

Feifei Wang, et al. “Fulminant Myocarditis Induced by Immune Checkpoint Inhibitor Nivolumab: A Case Report and Review of the Literature.” Journal of Medical Case Reports, vol. 15, no. 1, July 2021, pp. 1–5. EBSCOhost, https://doi.org/10.1186/s13256-021-02934-y.

APA

Feifei Wang, Yang Liu, Wei Xu, Changjing Zhang, Jianhong Lv, & Shaolin Ma. (2021). Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature. Journal of Medical Case Reports, 15(1), 1–5. https://doi.org/10.1186/s13256-021-02934-y

Chicago

Feifei Wang, Yang Liu, Wei Xu, Changjing Zhang, Jianhong Lv, and Shaolin Ma. 2021. “Fulminant Myocarditis Induced by Immune Checkpoint Inhibitor Nivolumab: A Case Report and Review of the Literature.” Journal of Medical Case Reports 15 (1): 1–5. doi:10.1186/s13256-021-02934-y.